Seegene Middle East

About Seegene Middle East

Seegene, which has devoted all its efforts to the acquirements of core technologies and valuable products in Molecular Diagnostics since established in 2000, has brought a paradigm shift in molecular diagnostics market that was previously dominated by a few major companies. Seegene was listed on KOSDAQ owing to its proprietary technologies and strong sales growth, and became the top of molecular diagnostics companies in Korea. Seegene's simultaneous and multiple detection technology which are unique and superior, have already surpassed the limits of conventional diagnostic technologies and provided a means of testing dozens of pathogens at once. Seegene Middle East FZE is a subsidiary company of Seegene Inc. South Korea. The company has been established for marketing, distribution and providing technical services in the territory of Middle East and Africa.

Mission

Making a contribution to public health with groundbreaking technology Top priority of Seegene is to change the paradigm for Molecular Diagnostics market. Seegene takes responsibilities for creation and commercialization of Molecular Diagnostic products and services that lead to an improvement to the public health and treatment of patients. We're wishing our groundbreaking technologies will open up the brighter and hopeful future for patients and their families.